RESUMEN
OBJECTIVE: To determine the best faecal calprotectin (FCP) cut-off level for differentiating between irritable bowel syndrome (IBS) and organic disease, particularly inflammatory bowel disease (IBD), in patients presenting with chronic diarrhoea. DESIGN: Retrospective analysis of patients who had colonoscopy, histology and FCP completed within 2â months. SETTING: District general hospital. PATIENTS: Consecutive new patients with chronic diarrhoea lasting longer than 4â weeks. INTERVENTIONS: Patients were seen by a single experienced gastroenterologist and listed for colonoscopy with histology. Laboratory investigations included a single faecal specimen for calprotectin assay (lower limit of detection: 8â µg/g), the results used for information only. MAIN OUTCOME MEASURES: Six FCP cut-off levels (range 8-150â µg/g) were compared against the 'gold standard' of histology: inflammation 'present' or 'absent'. RESULTS: Of 119 patients studied, 98 had normal colonoscopy and histology. The sensitivity of FCP to detect IBD at cut-off levels 8, 25 and 50â µg/g was 100% (with corresponding specificity 51%, 51%, 60%). In contrast, the lowest FCP cut-off, 8â µg/g, had 100% sensitivity to detect colonic inflammation, irrespective of cause (with negative predictive value (NPV) 100%). Importantly, 50/119 patients (42%) with FCP <8â µg/g had normal colonoscopy and histology. CONCLUSIONS: Our results suggest that using FCP to screen patients newly referred for chronic diarrhoea could exclude all without IBD and, at a lower cut-off, all without colonic inflammation, thus avoiding the need for colonoscopy. Such a major reduction has implications for resource allocation.
Asunto(s)
Úlcera Péptica Perforada/complicaciones , Úlcera Péptica/complicaciones , Antro Pilórico/patología , Anciano , Enfermedades Duodenales/diagnóstico , Enfermedades Duodenales/etiología , Fístula Gástrica/diagnóstico , Fístula Gástrica/etiología , Gastroscopía , Humanos , Fístula Intestinal/diagnóstico , Fístula Intestinal/etiología , MasculinoRESUMEN
BACKGROUND: Bile acid diarrhoea is a common, under-diagnosed cause of chronic watery diarrhoea, responding to specific treatment with bile acid sequestrants. We previously showed patients with bile acid diarrhoea have lower median levels compared with healthy controls, of the ileal hormone fibroblast growth factor 19 (FGF19), which regulates bile acid synthesis. AIM: To measure serum FGF19 and SeHCAT retention prospectively in patients with chronic diarrhoea. METHODS: One hundred and fifty-two consecutive patients were grouped according to (75) Se-homocholic acid taurine (SeHCAT) 7-day retention: normal (>15%) in 72 (47%) diarrhoea controls; ≤15% in 54 (36%) with primary bile acid diarrhoea, and in 26 (17%) with secondary bile acid diarrhoea. Fasting blood was assayed for FGF19, 7α-hydroxy-4-cholesten-3-one (C4) and total bile acids. RESULTS: FGF19 was significantly lower in the primary bile acid diarrhoea group compared with the diarrhoea control group (median 147 vs. 225 pg/mL, P < 0.001), and also in the secondary group (P < 0.006). FGF19 and SeHCAT values were positively correlated (rs = 0.44, P < 0.001); both were inversely related to C4. Other significant relationships included SeHCAT and body mass index (BMI)(P = 0.02), and FGF19 with age (P < 0.01). The negative and positive predictive values of FGF19 ≤ 145 pg/mL for a SeHCAT <10% were 82% and 61%, respectively, and were generally improved in an index including BMI, age and C4. In a subset of 28 primary patients, limited data suggested that FGF19 could predict response to sequestrant therapy. CONCLUSIONS: Reduced fibroblast growth factor 19 is a feature of bile acid diarrhoea. Further studies will fully define its role in predicting the response of these patients to therapy.
Asunto(s)
Ácidos y Sales Biliares , Diarrea/sangre , Factores de Crecimiento de Fibroblastos/sangre , Adulto , Ácidos y Sales Biliares/metabolismo , Bioensayo , Colestenonas/sangre , Diarrea/etiología , Diarrea/metabolismo , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Radioisótopos de Selenio/farmacocinética , Ácido Taurocólico/análogos & derivados , Ácido Taurocólico/farmacocinéticaRESUMEN
The case of a young woman with flare-up of Crohn's disease, who had an acute myocardial infarction due to the spontaneous dissection of the left anterior descending coronary artery, is reported. The literature on this rare condition is reviewed and a mechanism postulated for spontaneous coronary artery dissection in inflammatory bowel disease.